Blood Sugar, Insulin Resistance, and Cancer (Episode 20) episode artwork

EPISODE · Jan 14, 2025 · 15 MIN

Blood Sugar, Insulin Resistance, and Cancer (Episode 20)

from Functional Medicine in Cancer Care · host adming7b

Dr. Brian Lawenda's article argues that cancer is a metabolic disease fueled by high blood sugar and insulin resistance. He explains the Warburg Effect, where cancer cells preferentially use glucose for energy, and how insulin resistance, often undiagnosed, creates a perfect environment for cancer growth. The article emphasizes the importance of achieving optimal metabolic health, including maintaining low blood sugar levels, which can be monitored using Continuous Glucose Monitors (CGMs). Lawenda details lifestyle changes, such as diet, exercise, and stress management, to reverse insulin resistance and reduce cancer risk. Ultimately, the piece stresses proactive health choices to prevent cancer development.

Episode metadata supplied by the publisher feed · Published Jan 14, 2025

Embed this episode

Ready to play

Blood Sugar, Insulin Resistance, and Cancer (Episode 20)

0:00 15:19

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Functional Medicine in Cancer Care?

This episode is 15 minutes long.

When was this Functional Medicine in Cancer Care episode published?

This episode was published on January 14, 2025.

Can I download this Functional Medicine in Cancer Care episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!